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ABSTRACT
ADHD, ASD, and anxiety are three of the most common co-occurring disorders
in children with FXS leading to increased social, academic, and behavioral difficulties (Bailey,
Raspa, Olmsted, & Holiday, 2008). Early identification and treatment of these co-occurring
mental health disorders is essential to promote optimal outcomes; therefore, the study of early
precursors and underlying mechanisms of these disorders within a developmental framework is
warranted. The current dissertation includes two sequential and related studies investigating
impaired effortful control as a precursor and HPA axis dysfunction (measured through salivary
cortisol) as an underlying mechanism to the emergence of ADHD, ASD, and anxiety in young
boys with FXS. Results indicate that boys with FXS exhibit lower levels of effortful control and
higher levels of cortisol compared to typically developing controls; however, no significant
relationship between effortful control and cortisol was found. Additionally, significantly higher
levels of ASD symptoms were found in the FXS group. Due to significant variability in
individual ADHD, ASD, and anxiety trajectories across FXS and typically developing young
boys, no specific trend in developmental trajectories was found. Impaired effortful control did not
significantly relate to ADHD, ASD, or anxiety symptoms; however, increased cortisol levels
were found to relate to increased anxiety symptoms. Future research is necessary to better
understand the development of these disorders within FXS throughout childhood to assist with
early detection and treatment efforts. 	
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CHAPTER 1
INTRODUCTION
Fragile X Syndrome (FXS) is the most common inherited cause of intellectual
disability affecting as many as 1 in 2,500 males (Fernandez-Carvajal et al. 2009;
Hagerman, 2008). An expanded number of CGG trinucleotide repeats at the FMR1 gene
(Xq27.3) on the X chromosome causes FXS. The consequence of expanded CGG repeats
is a reduction of the expression of the fragile X mental retardation protein (FMRP),
leading to atypical brain development (Crawford, Acuna, & Sherman, 2001). The full
mutation of fragile X occurs when the expansions of CGG reach 200 or more while the
FX premutation occurs with 55-199 CGG repeats (Yu et al., 1991). Cognitive impairment
is one of the core features of FXS as IQ scores typically fall in the moderate range of
intellectual disabilities (IQ scores between 45 and 60; e.g. Loesch et al., 2002; Hall et al.,
2008; Hooper et al., 2008). Gender differences exist within the full mutation as females
typically experience less severe impairment compared to males due to the second X
chromosome available to produce the FMRP protein. Diagnoses can be made via pre- or
post-natal genetic testing; however, in the absence of a family history, FXS is not
typically diagnosed in boys until 37 months (Bailey, Raspa, Bishop, & Holiday, 2009).
While intellectual disabilities are almost hallmark in fragile X syndrome, nearly
80% of individuals with FXS have one or more co-occurring condition (Bailey, Raspa,
Olmstead, and Holiday, 2008). Attention-deficit hyperactivity disorder (ADHD; 84%),
autism spectrum disorder (ASD; 46%), and anxiety (70%) are three of the most
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commonly identified comorbid conditions within FXS (Bailey, Raspa, Olmstead, and
Holiday, 2008; Cordeiro, Ballinger, Hagerman, & Hessl, 2011). Individuals with FXS
and other co-occurring conditions tend to have poorer outcomes including greater
behavior problems, more restrictive school placements, lower levels of personal
independence, reduced language skills, and poorer social skills (e.g. Faraone, Biederman,
& Zimmerman, 2005; Handen, Janosky, & McAuliffe, 1997; Bailey et al., 2000; Hatton
et al., 2002; Kau et al, 2004). Additionally, many individuals with FXS experience subthreshold symptoms of ADHD, ASD, and anxiety and experience some of these negative
outcomes due to the symptom manifestations (Bailey et al., 2008). For example, more
than 80% of children with FXS have been treated for attention problems, 90% of children
with FXS exhibit one or more symptoms of ASD, and 56-70% of children with FXS
receive treatment for anxiety problems (Bailey et al., 2008; Clifford et al., 2007). Due to
the greater negative outcomes associated with comorbidities in FXS as well as subthreshold symptom manifestations, there is a greater need for early identification and
further research on the study of symptom severity to facilitate treatment efforts.
In children without FXS, ADHD typically emerges before the age of 5 with an
average diagnosis age of 7 (CDC, 2010) while ASD typically emerges between the ages
of 2 and 3 years with an average diagnosis age of 4 (Lord et al., 2006; CDC, 2012).
Anxiety disorders typically emerge during middle childhood before the age of 12
(Beesbo, Knappe, & Pine, 2009). While children with FXS exhibit higher rates of these
comorbid disorders, it is not known when comorbid conditions emerge in children with
FXS. In order to better understand the emergence of these disorders, a study of the
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precursors and underlying physiological mechanisms of these co-occurring disorders is
needed.
One such potential precursor is effortful control, which is broadly defined as the
ability to regulate responses. Deficits in effortful control exist in ADHD, ASD, and
anxiety in typically developing populations (Nigg, 2006; Konstantareas & Stewart, 2006;
Calkins & Fox, 2002). Physiological functioning, specifically the activity of the
hypothalamic-pituitary-adrenal (HPA) axis, which is responsible for managing biological
stress in humans, has been linked to the regulation of effortful control in typically
developing children (Watamura, Donzella, Ketes, & Gunnar, 2004) and may serve as an
underlying mechanism to the emergence of comorbid conditions in FXS.
While effortful control deficits and HPA axis dysfunction are associated with
ADHD, ASD, and anxiety in typically developing populations, the role of effortful
control and HPA axis functioning in the emergence of ADHD, ASD, and anxiety is not
well understood in typically developing children as well as children with FXS. Our initial
work showed low levels of effortful control in boys with FXS that did not improve over
time unlike typically developing boys that showed increased levels of effortful control
over time (Robinson et al., in preparation).	
  This dissertation includes two follow-up
studies that examine how effortful control and HPA axis dysfunction relates to comorbid
disorders within FXS.	
  More specifically, the first study investigates the relationship
between effortful control and HPA axis functioning, measured by salivary cortisol, in
boys with FXS compared to boys with typical development. The subsequent study
examines how effortful control and cortisol predict the emergence of ADHD, ASD, and
anxiety symptoms in boys with FXS compared to typically developing boys.
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The Neuroconstructivist Theory
Existing work suggests that ADHD, ASD, and anxiety within FXS are best
understood when behavioral and physiological factors are integrated within a
developmental framework (Cornish et al., 2004). The neuroconstructivistic framework
recognizes the role of genetics on brain development resulting in behavior and cognition
that may change with development (Cornish et al., 2004; see Figure 1.1). This theoretical
approach will be applied to the current studies to examine the potential precursors,
mechanisms, and developmental course of ADHD, ASD, and anxiety in boys with FXS
compared to boys with typical development.
Emergence of ADHD, ASD, and Anxiety in FXS
ADHD, ASD, and anxiety are three of the most commonly co-occurring
conditions in children with FXS (Bailey et al., 2008). Due to the high comorbidities, early
identification is essential to prevent or minimize these secondary conditions to promote
optimal outcomes. The study of precursors (i.e. effortful control) and underlying
mechanisms (i.e. cortisol) will help build an understanding of the emergence of these cooccurring disorders as well as the developmental pathways within FXS.
ADHD. Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental
disorder characterized by a pattern of symptoms of inattention and/or hyperactivity and
impulsivity present across multiple settings (American Psychiatric Association, 2013).
Symptoms of ADHD may include failure to pay close attention to details, difficulty
organizing tasks and activities, excessive talking, fidgeting, or an inability to remain
seated at appropriate times. Three subtypes of ADHD exist based on symptom
composition: predominately inattentive presentation, predominately hyperactive-
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impulsive presentation, or combined presentation (inattention and hyperactive-impulsive
symptoms). ADHD is the most prevalent childhood mental health diagnosis affecting
over 6% of all children with even higher rates in clinical groups (CDC, 2013; American
Psychiatric Association, 2013). Between 41% and 93% of children with FXS meet
criteria on parent rating checklist for ADHD (see Sullivan et al., 2006 for review). Of the
subtypes of ADHD, children with FXS ages 7 to 13 years meet criteria for the inattentive
presentation more than hyperactive-impulsive presentation or the combined presentation
(Sullivan et al., 2006).
There are several mechanisms that may affect the development of ADHD within
FXS including age and intellectual level. At early ages, children with FXS display
attention difficulties along with hyperactivity. As time progresses, the attention
difficulties persist while hyperactivity decreases (Wheeler et al., 2014; Hagerman, 2002).
Intellectual level may also play a large role in the emergence of comorbid FXS and
ADHD; however, compared to other groups with intellectual disabilities including Down
syndrome and idiopathic intellectual disability, boys with FXS exhibit higher rates of
inattention, restlessness, distractibility, and impulsivity, suggesting that symptoms of
ADHD are not limited to intellectual impairments (Turk, 1998).
Co-occurring ADHD and FXS may result in severe social, academic, and adaptive
behavior difficulties. Specifically, children with intellectual disabilities and ADHD
experience greater restrictive school placements, increased school suspensions, and
higher rates of inpatient psychiatric treatments compared to children with intellectual
disabilities without ADHD (Faraone, Biederman, & Zimmerman, 2005; Handen,
Janosky, & McAuliffe, 1997). As children with FXS and ADHD enter adulthood, they
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are at increased risk for educational, mental health, and legal problems (Pearson et al.,
2003) suggesting the need for identification in childhood and treatment throughout the
lifespan. In terms of treatment, stimulant medications used to target ADHD symptoms
have been shown to increase academic, attention, and physiological regulation skills in
boys with FXS (Roberts et al., 2011). While children with FXS and symptoms of ADHD
may encounter increased negative experiences compared to children with FXS without
symptoms of ADHD, positive effects are associated with targeted treatments. Therefore,
a better understanding of the precursors and underlying mechanisms of ADHD can assist
in the identification and treatment of ADHD symptoms in FXS.
ASD. Autism spectrum disorder (ASD) is a neurodevelopmental disorder
characterized by deficits in social communication and the presence of restricted,
repetitive patterns of behavior, interest, or activities (American Psychiatric Association,
2013). Social communication impairments may include deficits in social-emotional
reciprocity, deficits in nonverbal communication, or deficits in developing, maintaining,
or understanding relationships. Restricted and repetitive patterns of behavior, interest, or
activities may consist of motor stereotypies, echolalia, lining up toys, difficulties with
transitions, highly fixated interests, or hyper- or hypo-responsiveness to sensory input.
ASD affects 1 in 68 children and 1 in 42 boys (CDC, 2015). A strong genetic correlate is
evident within ASD as 10% of all children with ASD have a genetic or chromosomal
condition including FXS (CDC, 2012). Ninety percent of males with FXS exhibit one or
more symptom consistent with ASD and 60-75% of males and 20-45% of females with
FXS meet criteria for ASD (Clifford et al., 2007; Hall, Burns, Lightbody, & Reiss, 2008;
Harris et al., 2008; Klusek et al., 2014).
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The most common symptoms of ASD displayed by children with FXS include
language delays, poor eye contact, eye-gaze aversion, repetitive motor movements,
atypical sensory responses, social avoidance, hyperarousal, impulsivity, and attentional
impairments (Hatton et al., 2006; Hessl et al., 2001; Kaufmann et al., 2004). Children
with co-occurring FXS and ASD perform more similarly to children with idiopathic ASD
than children with FXS-only suggesting the impact of ASD symptoms in children with
FXS (Rogers et al., 2001). Co-occurring FXS and ASD leads to greater negative
outcomes including lower levels of adaptive behavior, poorer developmental and
intellectual abilities, greater problem behavior, delayed or reduced language skills, and
lower social competence compared to individuals with FXS without ASD and children
with idiopathic ASD (Cohen, 1995; Bailey et al., 2000; Rogers et al., 2001; Hatton et al.,
2002; Kau et al, 2004; Kaufman, 2004).
Due to increased rates of ASD associated with increased impairment, the risk
factors and underlying mechanisms of ASD continue to be studied. Intellectual level has
been shown to predict ASD; however, over 60% of children with ASD do not have an
intellectual disability; suggesting that IQ plays a limited role in the emergence of ASD
(Charman et al., 2011; CDC, 2012). Autism symptoms persist across childhood (Elmose
et al., 2013); however, few studies have examined the stability of ASD symptoms within
FXS. Stability in the diagnostic classification (ASD versus no ASD) has been established
within FXS (Hatton et al., 2006; Hernandez et al., 2009); however, ASD symptom
severity has been found to increase over time (Hatton et al., 2006) and decrease slightly
as social skills improved (Hernandez et al., 2009). These studies illustrate the stability of
ASD diagnoses (ASD versus no ASD), yet they do not clearly explain developmental

7

	
  

changes in ASD symptom severity that may occur within FXS (Hatton et al., 2006;
Hernandez et al., 2009).
Anxiety. Anxiety disorders are characterized by excessive and unrealistic worry
about routine tasks or events, or to a specific object or ritual (American Psychiatric
Association, 2013). Anxiety can be difficult to diagnosis in childhood as children
experience developmentally appropriate fears and worries; therefore, anxiety disorders
are identified when the fears and worries become excessive and/or unrealistic and
interfere with daily functioning (Creswell, Waite, & Copper, 2014). Many anxiety
disorders emerge during childhood with separation anxiety, generalized anxiety disorder,
and social phobia being the most common (see Table 1.1 for description; American
Psychiatric Association, 2013; Beesbo, Knappe, & Pine, 2011) Due to developmental
changes in childhood fears and worries, anxiety symptoms differ across ages (Weems &
Costa, 2005). Separation anxiety disorder is most prevalent in early childhood, typically
emerging before age 5 and becoming rare in adolescence while generalized anxiety
typically emerges around age 8 and increases in prevalence into adulthood (Copeland,
Angold, Shanahan, & Costello, 2015; Weems & Costa, 2005). Social phobia is most
prevalent in adolescents due to increased social demands and fears of failure and
criticism (Weems & Costa, 2005). Significant homotypic and heterotypic continuity has
been found in anxiety symptoms across childhood as young children with an anxiety
disorders continue to meet criteria for an anxiety disorder at later ages; however, the
specific anxiety disorder may change with age (e.g. separation anxiety disorder at age 5
to generalized anxiety disorder in adolescence; e.g. Bufferd et al., 2012; Gregory et al.,
2007). Anxiety disorders in childhood are also linked to increased rates of anxiety and
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depression in adulthood (Copeland et al., 2015; Woodward & Fergusson, 2001).
Additionally, most adults with anxiety disorders experienced clinical levels of anxiety in
childhood (Woodward & Fergusson, 2001).
About 12% of children from non-clinical community samples meet criteria for an
anxiety disorder at least once in their lifetime (Costello et al., 2011). Rates of anxiety are
even higher in FXS as 86% of males (aged 5 to 26) and 76% of females meet diagnostic
criteria for one or more anxiety disorder (Cordeiro, Ballinger, Hagerman, & Hessl, 2011).
Based on these high prevalence rates within FXS, anxiety disorders are the second most
commonly reported co-occurring disorder within FXS (Bailey et al., 2008; Cordeiro et
al., 2011). Many individuals with FXS who do not meet diagnostic criteria for an anxiety
disorder report features of anxiety disorders suggesting increased rates of anxiety
symptoms within FXS and the continuum of symptoms associated with FXS (Cordeiro et
al., 2011). Anxiety and social withdrawal have been shown to be core features of the FXS
behavioral phenotype based on both parent and teacher reports (Sullivan et al., 2007).
Anxiety symptoms within FXS most often manifest as avoidance behaviors, specific
phobias, and compulsions (Sullivan et al., 2007); however, symptoms of generalized
anxiety occur in higher functioning and older individuals with FXS (Kaufman, 2009).
Social anxiety has also been shown to be a prominent symptom in individuals with FXS
and may be a key feature in the co-occurrence of FXS and ASD (Kaufmann, Capone,
Clarke, & Budimirovic, 2008; Simonoff et al., 2008).
The study of precursors and underlying mechanism of anxiety within FXS is
important to assist in the identification of anxiety within FXS in order to promote
treatment. There are several mechanisms and precursors that may impact the
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development of anxiety within FXS including age, effortful control, and HPA
functioning. Anxiety disorders are highly heritable and have been found to persist across
the lifespan (Bittner et al., 2007; Ferdinand, Dieleman, Ormel, & Verhulst, 2007).
However, developmental changes in anxiety symptoms also exist. For example,
separation anxiety decreases with age (Costello et al., 2011). Within FXS, anxiety
symptoms show relative stability over time (Wheeler et al., 2014); however, age related
changes in mechanisms related to anxiety exist in children with FXS as
hyporesponsiveness is associated with infancy in FXS while hyperresponsiveness is
associated with early childhood ages (Roberts, Tonnsen, Robinson, & Shinkareva, 2012).
Due to evident developmental changes in anxiety symptoms in the general population as
well as age related changes in mechanisms related to anxiety within FXS, the
developmental trajectories of anxiety within FXS need further investigation.
Anxiety disorders can be difficult to clinically diagnose in children with FXS as
the diagnostic process often relies on verbal expression of symptoms, which may be
lacking in children with intellectual impairments (Bailey et al., 2008). Many treatments
and services for anxiety are linked to clinical diagnoses; therefore, some children with
FXS may not receive the appropriate services needed if appropriate diagnoses are not
made. Thus, children with FXS are not only at increased risk for displaying anxiety
symptoms and developing anxiety disorders, but they are also at increased risk for not
receiving targeted interventions (Bailey et al., 2008).
Impaired Effortful Control: Potential Precursor to ADHD, ASD, and Anxiety
Children with FXS exhibit impairments in effortful control that may serve as a
precursor to ADHD, ASD, and anxiety. One conceptualization of effortful control is
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through temperament, which is defined as individual differences in self-regulation, motor
reactivity, and emotional reactivity (Rothbart & Derryberry, 1981; Rothbart & Bates,
1998). The study of temperament allows for the investigation of constitutionally based
biological and behavioral factors that have been associated with mental health outcomes
(Rothbart & Derryberry, 1981; Rothbart & Bates, 1998). A number of definitions and
theories regarding temperament exist; however, the work of Mary Rothbart has the most
solid empirical basis to date.
Temperament factors are relatively stable over time yet influenced by
development, heredity, and experience allowing for the study of early states as well as
developmental changes (Rothbart & Derryberry, 1981; Rothbart & Bates, 1998).
Effortful control reflects one’s ability to suppress or inhibit a dominant response to
perform a subdominant response (Posner & Rothbart, 2000). Effortful control consists of
two major components: inhibitory control, which reflects one’s ability to inhibit
behavioral responses, and attentional control, which reflects one’s ability to focus and
shift attention when needed (Muris & Ollendick, 2005). Effortful control emerges during
the toddlerhood and early preschool years and continues to develop through childhood
and adolescence in children with typical development (Posner & Rothbart, 2000).
Effortful control impacts both behavioral and emotional development and, when
impaired, it can lead to increased risk for negative outcomes. In typically developing
children effortful control has been shown to be a risk factor for ADHD and anxiety (e.g.
Murray & Kochanska, 2002; Nigg, 2006; Eisenberg et al., 2001) as low levels of effortful
control relate to increased ADHD and anxiety symptoms. For example, in typically
developing children (boys and girls) followed longitudinally from 2 years to 5 years of
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age, lower levels of effortful control related to increased parent rated measures of
attention problems at age 4 (Murray & Kochanska, 2002). Effortful control has also been
shown to be the only temperament construct to differentiate children with ASD from
typically developing children ages 3 to 10 as children with ASD exhibit reduced levels of
effortful control (Konstantareas & Stewart, 2006). Additionally, in a study of boys ages
10 to 15 years comparing levels of effortful control in three groups: boys with ADHD,
boys with ASD, and typically developing boys, children in the clinical groups (ADHD/
ASD) scored significantly lower than typically developing children on measures of
effortful control further supporting the link between effortful control deficits and the
symptom manifestation of ADHD and ASD (Samyn, Roeyers, & Bijttebier, 2011). The
relationship between effortful control and anxiety symptoms has limited empirical
support compared to symptoms of ADHD and ASD. In a longitudinal study of typically
developing children ages 5 to 9, lower levels of effortful control related to increased
internalizing symptoms at ages 5 and 7 but not at age 9 (Eisenberg, Sadovsky, et al.,
2005). Additionally, adolescents with anxiety disorders displayed lower levels of effortful
control compared to controls (Vervoort et al., 2011). Effortful control served as a
protective factor for the adolescents with anxiety as higher levels of effortful control
related to decreased internalizing symptoms (Vervoort et al., 2011). While the
relationship between impaired effortful control and anxiety symptoms has been
established in adolescents, very little research has investigated the link between effortful
control and anxiety in young children. Overall, reduced levels of effortful control may
serve as a risk factor for ADHD, ASD, and anxiety in children.
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The study of effortful control in FXS is relatively new. A factor analytic study of
the temperament factors of the Child Behavior Questionnaire (i.e. negative affectivity,
surgency/ extraversion, and effortful control; Rothbart, Ahadi, Hershey, & Fisher, 2001)
revealed a factor structure within FXS similar to the original Rothbart factor structure in
typically developing children supporting the application of Rothbart’s factor structure in
the current studies (Roberts, Tonnsen, Robinson, McQuillin, & Hatton, 2013). Children
with FXS typically display lower levels of effortful control across ages compared to
typically developing children and show no changes in levels of effortful control over time
unlike typically developing children who show a steady increase across ages (Robinson et
al., in preparation; Posner & Rothbart, 2000). Additionally, greater autism symptoms
have been found to relate to lower levels effortful control in young boys with FXS
(Robinson et al., in preparation). The relationship between effortful control and ADHD
and anxiety symptoms in children with FXS has not been examined to date. Overall,
children with FXS exhibit impairments in effortful control across ages, which may serve
as a precursor for mental health disorders as is observed in children with typical
development. However, effortful control has not been examined as a potential precursor
to ADHD, ASD, and ADHD symptoms in children with FXS.
Physiological Functioning: Potential Mechanism in ADHD, ASD, and Anxiety
The relationship between physiological functioning and behavior is complex and
multifaceted. Theoretical advances, like the neuroconstructivist model, have facilitated
this work in FXS with recognition of the multiple etiological mechanisms for disorders
including genetic, neurobiological, and environmental factors that operate in a
transactional manner over time. There are numerous reasons to incorporate physiological
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processes in research of typically developing individuals and those with
neurodevelopmental disabilities like FXS. First, physiological data may help identify
underlying relevant physiological mechanisms in the absence of clear overt behavioral
symptoms. Second, physiological measures can provide a measure of response that may
not otherwise be available which is particularly relevant in very young children or those
with limited language or cognitive function. Third, physiological markers can document
biological vulnerability to later-emerging symptoms or disorders both within and across
etiologically-specific groups. Finally, physiological markers may reflect individual
differences that could affect treatment response.
While a number of physiological systems are implicated in the regulation of
effortful control, the hypothalamic- pituitary-adrenal (HPA) axis has been a focus given
its role in managing biological stress responses in humans. As part of the neuroendocrine
system, the HPA axis plays a critical role in an organism’s ability to adapt to
biopsychosocial challenges (McEwen, 2004). When stressed, the HPA axis stimulates the
hypothalamus to secrete corticotrophin-releasing hormone (CRH), which causes the
pituitary to release ACTH that ultimately stimulates the adrenal gland to secrete the
hormone cortisol. Cortisol is used to measure stress and is found in plasma but can also
be reliably measured in saliva. The activity of the HPA axis system is part of normal
coping and stress regulation (Gunnar, 1987); however, HPA axis dysfunction, including
both under- and over-activity, leads to negative effects on brain development resulting in
learning, memory, and attention deficits (see Sandi & Pinelo-Nava, 2007 for review).
This suggests an inverse U-shaped relationship between cortisol levels and cognitive
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functioning exists such that significantly high and significantly low levels of cortisol lead
to impairments. Optimal performance is linked with moderate levels of cortisol.
HPA axis dysfunction is common in many clinical groups including those with
ADHD, ASD, and anxiety disorders. Specifically, children with ADHD alone tend to
exhibit reduced levels of cortisol compared to typically developing children in the
morning, at bedtime, and during stressful events (Isaksson, Nilsson, Nyberg Hogmark, &
Lindblad, 2012; Ma et al., 2011; Isaksson, Nilsson, Lindbald, 2013). Children with ASD
also display HPA axis dysfunction. In a study evaluating stress regulation during
psychosocial stress situations, typically developing children showed significant decreases
in stress over time while children with ASD exhibited increased cortisol levels following
the stress situation suggesting impairments in stress regulatory abilities for children with
ASD (Corbett, Schupp, & Lanni, 2012). However, when not encountering a stressful
situation, children with ASD tend to exhibit reduced levels of cortisol compared to
typically developing children (Ćurin, Terzić, Petković, et. al, 2003). High baseline
cortisol levels (see Costello et al., 2011 for review) have been shown to serve as risk
factors for the development of anxiety. Overall, anxiety disorders are typically associated
with chronically high levels of cortisol (Costello et al., 2011) while children with ADHD
and ASD typically exhibit reduced levels of cortisol (e.g. Ma, Chen, Chen, Liu, & Wang,
2011; Ćurin, Terzić, Petković, et. al, 2003). Due to the known link between
physiological functioning and mental health disorders, HPA axis activity may operate as
an underlying mechanism of ADHD, ASD, and anxiety suggesting that over- or underactivity of the HPA axis may lead to impairments in behavior regulation consistent with
symptoms of ADHD, ASD, or anxiety.

15

	
  

HPA axis dysfunction is evident in children with FXS. Specifically, boys with
FXS tend to have chronically high levels of cortisol compared to typically developing
children suggesting increased arousal and stress reactivity (Wisbeck et al. 2000; Hessl et
al., 2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Hessl, Rivera, & Reiss, 2004).
These high levels of cortisol have also been linked to symptoms of ADHD and anxiety
within FXS in some studies (Hessl et al., 2002) but not others (Hessl, Glaser, DyerFriedman, & Reiss, 2006). Conversely, reduced levels of cortisol have been found to
relate to ASD specific symptoms in boys with FXS (Hall et al., 2008). Compared to
typically developing children and boys with FXS and no ASD, boys with co-occurring
FXS and ASD are less able to regulate their response to a stressful event which was
associated with elevated initial levels that may have constrained reactivity (Roberts et al.,
2009). These results suggest impairments in normal HPA axis functioning in children
with FXS. These elevated or decreased releases of cortisol may serve as an underlying
mechanism of effortful control impairments leading to the emergence of ADHD, ASD, or
anxiety.
There is both theoretical and empirical evidence to link effortful control and HPA
axis function given that they both represent aspects of regulation. Children with typical
development with higher levels of effortful control produced lower levels of baseline
cortisol when controlling for age in typically developing children ages 12 to 36 months
(Watamura, Donzella, Ketes, & Gunnar, 2004). Additionally, higher levels of cortisol
during a challenging situation relate to lower levels of effortful control in children of
typical development suggesting that increased HPA axis functioning may serve as an
underlying mechanism of effortful control with high levels signaling poor physiological
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regulation (Dettling, Parker, Lane, Sebanc, & Gunnar, 2000). While the relationship
between cortisol and effortful control has been established in typically developing
samples, this link has yet to be studied within FXS supporting the need for this study
focused on such factors.
Current Studies
ADHD, ASD, and anxiety are complex mental health disorders that require the
integration of behavioral and physiological factors to fully understand their emergence
and development over time. Due to the increased rates of ADHD, ASD, and anxiety
disorders within FXS and even higher rates of symptoms of these disorders, this singlegene disorder provides an ideal model to study precursors and underlying mechanisms of
these disorders. Using a neuroconstructivistic approach, the following sequential studies
used a dimensional approach to assess the precursors and underlying mechanisms of
ADHD, ASD, and anxiety symptoms within FXS. The neuroconstructivistic approach
highlights the bi-directional nature of multiple factors suggesting that precursors to these
mental health disorders interact with one another over time. Therefore, the following
sequential studies aimed to examine the role of development in the emergence and
stability of ADHD, ASD, and anxiety symptoms. The first study examined whether
physiological dysfunction, as measured by cortisol, serves an underlying mechanism of
effortful control impairments in children with FXS compared to typically developing
children. The subsequent study examined how impaired effortful control and
physiological dysfunction relate to the emergence of ADHD, ASD, and anxiety in boys
with FXS compared to typically developing boys.
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Study 1: What is the relationship between effortful control and cortisol in young
boys with FXS compared to typically developing boys controlling for chronological
age and developmental level?
It is hypothesized that boys with FXS will exhibit lower levels of effortful control and
increased cortisol levels compared to typically developing boys. A negative relationship
between effortful control and cortisol is anticipated for both groups.
Study 2: Does effortful control and cortisol predict the emergence of ADHD, ASD,
or anxiety symptoms in young boys with FXS compared to typically developing boys
while controlling for chronological age and developmental level?
It is hypothesized that children with FXS will exhibit higher levels of ADHD, ASD, and
anxiety symptoms with relative stability across ages. Lower levels of effortful control are
hypothesized to predict higher levels of ADHD, ASD, and anxiety symptoms in both
groups. Higher levels of cortisol are expected to relate to increased levels of anxiety
symptoms. Lower levels of cortisol are expected to relate to increased levels of ADHD
and ASD symptoms.
The current dissertation included two sequential studies that overlap but are not
identical. Due to differences in sample sizes and measures used, the methods and results
are discussed for each study separately. While these studies have slight differences, they
are interrelated and impact one another.
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Table 1.1. Description of Anxiety Disorders in Childhood
Anxiety Disorder

Description
excessive worry about separation from a major
Separation Anxiety Disorder
attachment figure
excessive and uncontrolled worry across
Generalized Anxiety Disorder
multiple situations and activities
intense and persistent fear of social or public
Social Phobia
situations
(American Psychiatric Association, 2013)
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Table 1.2. Labels and definitions of scales comprising effortful control.
Definition

ECBQ*

CBQ*

Ability to sustain attention on a task or
object.

X

X

Attentional
Shifting

Capacity to shift attention from on task or
object to another.

X

Inhibitory
Control

Ability to suppress actions or responses.

X

X

Low-Intensity
Pleasure

Enjoyment or pleasure resulting from
stimuli of low intensity, rate, complexity,
novelty, or incongruity.

X

X

Attention
Focusing

Perceptual
Sensitivity

Ability to detect slight, low-intensity
stimuli from the environment.

Desire for closeness and pleasure with
X
others.
Positive affect related to changes in
Smiling and
stimulus intensity, rate, complexity, and
Laughter
incongruity
Based on factor analytic studies (Putnam et al., 2006; Rothbart et al., 2001)

X

Cuddliness
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Figure 1.1. The Neuroconstructivistic Approach	
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CHAPTER 2
STUDY 1
2.1 METHODS
Participants
Participants for the current study included 46 males with FXS and 17 typically
developing males (TD). Participants were drawn from two existing datasets. The first is
an extant dataset of a series of longitudinal studies on the early development of children
with FXS from the University of North Carolina. The second is from an ongoing study at
the University of South Carolina focusing the early emergence of ASD in young children
with FXS. For both the UNC and USC studies, recruitment of participants took place
through research registries, mailings, and listserve emails. Criteria for the current study
included the participants’ first assessment after the age of 17 months with data from a
parent-rated temperament questionnaire, parent interview, and salivary samples. This
early assessment time was chosen due to the study goals of examining the emergence of
behaviors. Typically developing children were identified as those without any suspected
or identified delays or disabilities as well as no history of FXS. These children also
scored within two standard deviations of the mean on a measure of developmental level.
The typically developing group was matched with the FXS participant group on a broad
age range. Only males were included in the current study due to greater heterogeneity in
the phenotype of females with FXS. Participants with FXS ranged in age from 18 months
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to 7 years (M=4.21, SD=1.64) while TD participants ranged in age from 18 months to 4
years (M=2.72, SD=1.64). See Table 2.1 for an overview of the data.
Measures
Effortful Control. Parent-rated temperament questionnaires measuring aspects of
reactivity and self-regulation were collected at each assessment. To best examine
temperament longitudinally across childhood, multiple temperament scales were
developed to appropriately account for developmental changes. Due to the longitudinal
nature of the current study, two temperament scales were used including the Early
Childhood Behavior Questionnaire (ECBQ; Putnam, Gartstein, & Rothbart, 2006) and
the Child Behavior Questionnaire (CBQ; Rothbart et al., 2001). The ECBQ is used for
children ages 16 to 35 months while the CBQ is used for children ages 3 to 7 years.
Factor analytic studies exist for the scales and the following three temperament
constructs are consistently reported: effortful control, surgency/extraversion, and negative
affectivity (Putnam et al., 2006; Putnam, Rothbart, & Garstein, 2008; Rothbart et al.,
2001). The current study focused on effortful control and computed this construct using
the scales with the highest factor loadings per published findings. While the ECBQ, and
CBQ are theoretically unified, item and scale content overlap but are not identical given
the change in behavioral expression associated with developmental factors (e.g., attention
focusing in toddler aged children is expressed differently than attention focusing for
children in middle childhood). Thus, there are minor differences in the factor composition
of effortful control across scales reflecting this developmental effect (see Table 1.2 for
review). For the ECBQ, effortful control is comprised of attention focusing, attentional
shifting, inhibitory control, low-intensity pleasure, and cuddliness (see Table 1.2 for scale
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definitions; Putnam, Garstein, & Rothbart, 2006), while the CBQ effortful control
composite is comprised of attention focusing, inhibitory control, low-intensity pleasure,
perceptual sensitivity, and smiling and laughter (Rothbart et al., 2001).
These temperament scales have been extensively evaluated and show strong
convergent and discriminate validity, inter-rater reliability, internal reliability, and
reliability across ages (Putnam, Rothbart, & Garsten, 2008). Effortful control in early
childhood predicts effortful control in later childhood suggesting strong homotypic
continuity (Putnam, Rothbart, & Garstein, 2008). Consistent with previous work, the
effortful control scale was computed by taking the mean of the standardized temperament
scales (see Table 1.2). For the current study, internal reliability estimates of effortful
control ranged from .54 to .84. For the FXS group, effortful control scores ranged from 2.24 to 1.19 (M=-0.25, SD=0.9). For the TD group, effortful control scores ranged from 0.77-2.33 (M=0.67, SD=0.93).
Salivary Cortisol. Salivary samples were collected two times during each
assessment to measure cortisol. The current study used only the first salivary sample
termed “baseline cortisol,” which was collected within 15 minutes of the start of the
assessment to represent pre-assessment cortisol levels. The second salivary sample
termed “reactivity” was not included in the current study for two reasons. First, the
current study aimed to explore the role of HPA axis functioning when not undergoing a
stressful situation. Secondly, the reactivity sample was missing for many of the
participants in the current study significantly limiting the sample size. The salivary
samples were collected using a Salivette (Salimetrics, LLC 2005), which resembles an
oral cotton swab that the participant saturated in his mouth for at least one minute.
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Participants were asked to avoid consumption of food or liquid (except water) 30 minutes
before the sample. Assessment times were scheduled to start and end at the approximate
same time each day and the collection time was recorded to control for diurnal variation
in cortisol levels. The saliva samples were processed using the Salimetrics’ Salivary
Cortisol Enzyme Immunoassay kit (EIA; Salimetrics LLC, 2005). Serum and saliva
cortisol are positively correlated using the Salimetrics EIA (r=.91, p<.0001; Salimetrics
LLC, 2005). The mean inter-assay coefficient of variation for the current sample was
6.53 (Range=5.40- 8.11%) Each sample was assayed twice and the correlations among
the assays was >.95. Cortisol levels are reported in micrograms/deciliter. Across all
observations, cortisol levels varied from 0.04 to 1.79 (M=0.28, SD=0.3) for the FXS
group and 0.04 to 0.52 (M=0.11, SD=0.11) for the TD group.
Developmental Level. The Vineland Adaptive Behavior Scale (VABS; Sparrow,
Balla, Cicchetti, & Doll, 1984; VABS- 2; Sparrow, Cicchetti, & Balla, 2005) is a semistructured interview that measures adaptive behavior skills in 4 domains: communication,
socialization, daily living skills, and motor skills. Mothers completed the interview of
their child’s current abilities at each assessment. Domain and adaptive behavior
composite (ABC) standard scores were calculated. For the current study, two versions of
the Vineland were used due to the release of an updated version during the data collection
period. The VABS has been extensively used with typically developing and clinical
populations. Test-retest reliability estimates vary around .80 suggesting stability over
time. Uniformality among raters has also been found as inter-rater reliability estimates
range from .6 to .7. In terms of validity, the VABS has been shown to correlate well with
other measures of adaptive behavior including Adaptive Behavior Inventory for Children
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(ABIC; .58) and AAMD Adaptive Behavior (.40 to .70). Overall, the VABS is a robust
well-supported measure of developmental skills for children. The VABS is commonly
used as a measure of development in children with FXS as it can be very difficult to
obtain valid intelligence scores (Rogers et al., 2001; Hatton et al., 2006; Kaufman et al.,
2004). This scale is also widely used with children with ASD and has been shown to
positively correlate with measures of cognitive ability and mental age in children with
ASD supporting the use of this scale in the current study (Wells, Condillac, Perry, &
Factor, 2009; Freeman, Del’Homme, Guthrie, & Zhang, 1999). In the current sample,
ABC scores ranged from 36 to 119 for the FXS group (M=60.39, SD=13.62) while the
total scores for the TD group ranged from 85 to 114 (M=100.59, SD=8.62). These ABC
scores were found to highly correlate (r=0.91) with a concurrent and direct assessment of
developmental skills measured by the Early Learning Composite score of the Mullen
Early Scales (Mullen, 1995).
Procedures
The effortful control and salivary cortisol measures were all completed within a
larger assessment battery. Interested parents were provided with study information over
the phone and through email. All children who met the inclusion/exclusion criteria were
enrolled in the study. Informed consent was completed for each participant by the parent
and the individual assessments were conducted within the family home. The parent rated
scales were completed within two weeks before or after the in-person assessment.
Following each assessment, families were given a small stipend and a summary report of
their child’s developmental skills. All data were scored and double-checked at 100%. The
data were then double-entered and verified for 20% accuracy.
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Data Analysis
All analyses were performed using the R Project for Statistical Computing and the
NLME package (version 2.14.2; R Foundation for Statistical Computing, 2012). To
address the hypotheses, analyses were conducted through a series of steps. First,
descriptive analyses and correlations were conducted. Second, initial analyses of
covariance (ANCOVA) and linear regression models were built to examine potential
predictors. The final step included determining the models with the best fit. Diagnostic
analyses of the data were performed to examine the key assumptions of ANCOVA and
linear regression. Plots of residual and error terms supported the independence and
normality of residuals, homoscedasticity of variance, and homogeneity of regression
slopes. No influential data points were found, including outliers. Due to a skewed
distribution, cortisol was transformed using a log base 10 transformation.
Analyses of covariance (ANCOVA) were conducted to compare mean levels of
effortful control and cortisol across the FXS and TD groups controlling for age.
Developmental level was tested as a covariate but was not independent of group
membership so it was not included in the ANCOVA. Multiple linear regression models
were conducted to assess the relationship between effortful control and cortisol. The final
model included cortisol predicting effortful control while controlling for age,
developmental level, and group membership. , Y=B0+ B 1(Age)+ B 2(Developmental
Level)+ B 3(Group)+ ßB4(Cortisol)+ ei, Interaction effects were tested examining the role
of group membership, age, and developmental level with cortisol.; however, due to
decreased model fit and non-significant findings, these interaction effects were not
included in the final model.
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2.2 RESULTS
ANCOVA results revealed that when controlling for age, boys with FXS
exhibited significantly lower levels of effortful control (M=-0.25, SD=0.9) compared to
typically developing boys (M=0.67, SD=0 .93, F(2,60)=12.11, p<.0001). Boys with FXS
exhibited significantly higher levels of cortisol (M=0.28, SD=0.3) compared to boys with
typical development (M= 0.11, SD= 0.11, F(2,60)=14.85, p=.0003) when controlling for
age. Figure 2.1 illustrates this comparison.
The results (Table 2.2) of the linear regression model examining the relationship
between cortisol and effortful control indicated that when controlling for age,
developmental level, and group membership, cortisol levels did not significantly predict
effortful control (B=0.22, p=0.53). Increasing age (B=0.24, p=0.01) and developmental
level (B=0.03, p=.005) did significantly predict higher levels of effortful control. Due to
the null finding, a post-hoc power analysis using R was conducted and indicated a
11.56% chance of detecting a small effect (.02), a 64.73% chance of detecting medium
effect (.15) and a 96.66% chance of detecting a large effect (.35) based on the sample size
(n=63), model predictors (df=4), and significant level (p=.05). These results suggest that
sufficient power was available to detect a medium and large effect.
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Table 2.1. Study 1 Descriptives
Group
FXS (n=46)

TD (n=17)

M (SD)

Range

M (SD)

Range

Age (years)

4.21 (1.64)

1.47 – 7.81

2.76 (0.78)

1.54 – 4.15

Developmental Level

60.39 (13.62)

36 – 119

100.59 (8.62)

85 – 114

Effortful Control

-0.25 (0.9)

-2.24 – 1.19

0.67 (0.93)

-0.77 – 2.33

Cortisol

0.28 (0.3)

0.04 -1.79

0.11 (0.11)

0.04 – 0.52

Developmental Level= Vineland Adaptive Behavior Composite Score
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Table 2.2. Linear Regression Results, Outcome: Effortful Control
Variable

B

SE

t-value

p

F

df

p

R2

Intercept

-3.01

1.15

-2.61

0.01

7.02

4, 58

0.0001

0.30

Age (years)

0.24

0.08

2.87

0.005

Developmental
Level

0.03

0.01

3.29

Group

-0.06

0.44

-0.14

0.89

Cortisol

0.22

0.34

0.64

0.53

0.001

Note: n= 63; Developmental Level= Vineland Adaptive Behavior Composite Score
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FXS

TD

FXS

Figure 2.1. Group comparisons of mean levels of effortful control and cortisol.
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CHAPTER 3
STUDY 2
3.1 METHODS
Participants
Participants for the current study included 60 males with FXS assessed between 1
and 3 times and 34 males with typical development (TD) assessed between 1 and 2 times
with a one-year interval between all assessments. Participants were drawn from two
existing datasets. The first is an extant dataset of two longitudinal studies on the early
development of children with FXS from the University of North Carolina. The second is
from an ongoing study at the University of South Carolina focusing the early emergence
of ASD in young children with FXS. For both the UNC and USC studies, recruitment of
participants took place through research registries, mailings, and listserve emails.
The current study included participants with FXS and of typical development with
data from a parent-rated temperament questionnaire, a parent-rated behavior
questionnaire, salivary samples, a parent interview of developmental disabilities, and
observer ratings of ASD symptoms. Typically developing children were identified as
those without any suspected or identified delays or disabilities as well as no history of
FXS. These children also scored within two standard deviations of the mean on a
measure of developmental level. Typically developing boys were matched within a broad
chronological age range (1.5- 5 years). Only males were included in the current study due
to greater heterogeneity in the phenotype of females in females with FXS.

32	
  

	
  

Participants with FXS were assessed between 1 and 3 times totaling 118
observations (Time 1: N= 60, Time 2: N=42, Time 3: N=16) while the TD participants
were assessed one to two times yielding 39 total observations (Time 1: N=34, Time 2:
N=5). See Table 3.1 for an overview of the observations. Across all observations,
participants with FXS ranged in age from 18 months to 5.9 years (M=4.14, SD= 1.09)
while the typically developing group ranged in age from 23 months to 4.5 years (M=3.12,
SD= 0.81). Table 3.2 reports the characteristics of the participants at the first observation
by group.
Measures
ADHD and Anxiety Symptoms. Symptoms of ADHD and anxiety were assessed
using the Child Behavior Checklist (CBCL; Achenbach, 1991; Achenbach & Rescorla,
2001). The CBCL is a parent-rated measure of adaptive and maladaptive behaviors.
When completing the scale, parents were asked to think about their child’s behavior over
the past 6 months. This widely used measure assesses several areas of behavioral and
emotional functioning in children age 1.5 to 18 years. The version for ages 1.5 to 5 years
was used in the current study to best assess the emergence of ADHD and anxiety
symptoms. A large normative sample was collected for the CBCL. Strong reliability and
validity has been documented with estimates of test-retest reliability at r=.95 (Achenbach
and Rescorla 2001; Achenbach et al. 2003). The CBCL is frequently used with children
with FXS (Tonnsen et al., 2013; Hatton et al., 2002; Kau et al., 2004). For the current
study, two specific scales were drawn from both forms that assess the diagnostic criteria
of ADHD and anxiety disorders based on the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (American Psychiatric Association, 1994). High internal reliability
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estimates of .85 for the ADHD problems scale and .77 for the anxiety problems scale
have been reported (Nakamura, Ebesutani, Bernstein, & Chorpita, 2008).
For the DSM-specific scales, raw scores are converted to T-scores that rank in
average range (≤65), borderline clinical range (66-69), or clinically significant range
(≥70). The average T-score for ADHD symptoms was for the FXS group 59.18
(SD=6.96, range=50-76) and 52.38 (SD=3.57, range=50-64) for the TD group. In the
FXS group, 22.5% percent (n=18) of the participants had elevated ADHD scores at one
or more assessment and no participants in the TD group had ADHD T-scores above 65.
The average T-score for anxiety symptoms was 55.55 (SD=7.83, range= 50-86) for the
FXS group and 52.69 (SD=5.43, range=50-73) for the TD group. Seven FXS participants
(8.75%) had anxiety T-scores above 65 at one or more assessment while two participants
(0.06%) in the TD group had elevated anxiety scores.
The publisher recommends using raw scores in research as the T-scores are
truncated at 50 (Achenbach, 1991) resulting in a floor effect. For the current sample, the
average raw score for ADHD symptoms was 7.33 for FXS group (SD=2.71, range= 0-16)
and 4.15 for the TD group (SD=2.21, range=1-9). For children with FXS, the average raw
score for anxiety 3.78 (SD=2.44, range= 0-15) and 2.59 for the TD group (SD=2.44,
range=0-10). Raw scores were standardized for all analyses.
ASD Symptoms. The Childhood Autism Rating Scale (CARS; Schopler,
Reichler, DeVellis, & Daly, 1980) is an examiner rating scale of behavioral symptoms of
ASD. Children are rated in 15 areas related to ASD characteristics including social
behaviors, activity level, adaptation, and communication. A composite score of 15 to 60
is obtained from the sum of the items yielding a measure of symptom severity and ASD

34	
  

	
  

diagnoses are consistent with scores of 30 or above. The CARS was completed by
examiners following each assessment based on behaviors observed as well as on parent
reported behaviors. The CARS is a well-established measure with extensive reliability
and validity evidence (Schopler, Reichler, DeVellis, & Daly, 1980). The measure has
high internal consistency ratings above .90, inter-rater reliability estimates around .71,
test-retest reliabilities ranging from .90 at one year apart to .77 at two years. Furthermore,
strong sensitivity and specificity values of .88 or higher support the accuracy of the
instrument in identifying individuals with and without ASDs. Although not an ASD
diagnostic measure, the CARS is often used in research settings to assess ASD behaviors
in children with FXS (Hatton et al., 2006; Shanahan, Roberts, Hatton, Reznick, &
Goldsmith, 2008). The CARS is standardized on children ages 2 and up. Due to the age
restriction, observations before 24 months were removed from the ASD symptoms
analyses.
In the current sample, CARS scores ranged from 16.5 to 42 for the FXS group
(M=27.09, SD=5.47) while the total scores for the TD group ranged from 15 to 29
(M=16.06, SD=2.7). Twenty-six of the FXS participants (32.5%) had scores of 30 or
higher at one or more assessment. No participants in the TD group had CARS scores
above 29.
Effortful Control. Parent-rated temperament questionnaires measuring aspects of
reactivity and self-regulation were collected at each assessment. To best examine
temperament longitudinally across childhood, multiple temperament scales were
developed to appropriately account for developmental changes. Due to the longitudinal
nature of the current study, two temperament scales were used including the Early
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Childhood Behavior Questionnaire (ECBQ; Putnam, Gartstein, & Rothbart, 2006) and
the Child Behavior Questionnaire (CBQ; Rothbart et al., 2001). The ECBQ is used for
children ages 16 to 35 months while the CBQ is used for children ages 3 to 6 years. For
all scales, mothers indicated how often their child displayed specific behaviors based on a
scale of 1 (never) to 7 (always).
Factor analytic studies exist for the scales and the following three temperament
constructs are consistently reported: effortful control, surgency/extraversion, and negative
affectivity (Putnam et al., 2006; Putnam, Rothbart, & Garstein, 2008; Rothbart et al.,
2001). The current study focused on effortful control and computed this construct using
the scales with the highest factor loadings per published findings. While the ECBQ and
CBQ are theoretically unified, item and scale content overlap but are not identical given
the change in behavioral expression associated with developmental factors (e.g., attention
focusing in toddler aged children is expressed differently than attention focusing for
children in middle childhood). Thus, there are minor differences in the factor composition
of effortful control across scales reflecting this developmental effect (see Table 1.2 for
review). For the ECBQ, effortful control is comprised of attention focusing, attentional
shifting, inhibitory control, low-intensity pleasure, and cuddliness (see Table 1.2 for scale
definitions; Putnam, Garstein, & Rothbart, 2006), while for the CBQ, effortful control
composite is comprised of attention focusing, inhibitory control, low-intensity pleasure,
perceptual sensitivity, and smiling and laughter (Rothbart et al., 2001).
These temperament scales have been extensively evaluated and show strong
convergent and discriminate validity, inter-rater reliability, internal reliability, and
reliability across ages (Putnam, Rothbart, & Garsten, 2008). Effortful control in early
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childhood predicts effortful control in later childhood suggesting strong homotypic
continuity (Putnam, Rothbart, & Garstein, 2008). Consistent with previous work,
effortful control scale was computed by taking the mean of the standardized temperament
scales (see Table 2). For the current study, internal reliability estimates of effortful
control ranged from .70 to .87. Across all observations, levels of effortful control varied
from -2.74 to 2.16 (M=-0.22, SD= 0.96) for the FXS group and -0.97 to 2.35 (M=0.68,
SD=0.8) for the TD group.
Salivary Cortisol. Salivary samples were collected two times during each
assessment to measure cortisol. The current study used the first salivary sample termed
“baseline cortisol,” which was collected within 15 minutes of the start of the assessment
to represent pre-assessment cortisol levels. The second salivary sample termed
“reactivity” was not included in the current study for two reasons. First, the current study
wanted to explore the role of HPA axis functioning when not undergoing a stressful
situation. Secondly, the reactivity sample was missing for many of the participants in the
current study significantly limiting the sample size and power. The salivary samples
were collected using a Salivette (Salimetrics, LLC 2005), which resembles an oral cotton
swab that the participant saturated in his mouth for at least one minute. Participants were
asked to avoid consumption of food or liquid (except water) 30 minutes before the
sample. Assessment times were scheduled to start and end at the approximate same time
each day and the collection time was recorded to control for diurnal variation in cortisol
levels. The saliva samples were processed using the Salimetrics’ Salivary Cortisol
Enzyme Immunoassay kit (EIA; Salimetrics LLC, 2005). Serum and saliva cortisol are
positively correlated using the Salimetrics EIA (r=.91, p<.0001; Salimetrics LLC, 2005).
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The mean inter-assay coefficient of variation for the current sample was 6.53
(range=5.40- 8.11%). Each sample was assayed twice and the correlations among the
assays was >.95. Cortisol levels are reported in micrograms/deciliter. Cortisol levels were
included for the first time point for a subset of the sample (FXS N: 25; TD N: 21) due to
missing data at subsequent assessment times. Cortisol levels varied from 0.04 to 1.75
(M=0.33, SD=0.34) for the FXS group and 0.04 to 0.52 (M=0.14, SD=0.13) for the TD
group.
Developmental Level. The Vineland Adaptive Behavior Scale (VABS; Sparrow,
Balla, Cicchetti, & Doll, 1984; VABS- 2; Sparrow, Cicchetti, & Balla, 2005) is a semistructured interview that measures adaptive behavior skills in 4 domains: communication,
socialization, daily living skills, and motor skills. Mothers completed the interview of
their child’s current abilities at each assessment. Domain and adaptive behavior
composite (ABC) standard scores were calculated. For the current study, two versions of
the Vineland were used due to the release of an updated version during the data collection
period. The VABS has been extensively used with typically developing and clinical
populations. Test-retest reliability estimates vary around .80 suggesting stability over
time. Uniformality among raters has also been found as inter-rater reliability estimates
range from .6 to .7. In terms of validity, the VABS has been shown to correlate well with
other measures of adaptive behavior including Adaptive Behavior Inventory for Children
(ABIC; .58) and AAMD Adaptive Behavior (.40 to .70). Overall, the VABS is a robust
well-supported measure of developmental skills for children. The VABS is commonly
used as a measure of development in children with FXS as it can be very difficult to
obtain valid intelligence scores (Rogers et al., 2001; Hatton et al., 2006; Kaufman et al.,
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2004). This scale is also widely used with children with ASD and has been shown to
positively correlate with measures of cognitive ability and mental age in children with
ASD supporting the use of this scale in the current study (Wells, Condillac, Perry, &
Factor, 2009; Freeman, Del’Homme, Guthrie, & Zhang, 1999). In the current sample,
ABC scores ranged from 33 to 85 for the FXS group (M=58.25, SD=9.26) while the total
scores for the TD group ranged from 85 to 118 (M=100, SD=9.14). These ABC scores
were found to highly correlate (r=0.84) with a concurrent and direct assessment of
developmental skills measured by the Early Learning Composite score of the Mullen
Early Scales (Mullen, 1995).
Procedures
The parent rated temperament and behavior scales, developmental measures,
examiner rating, and salivary samples were all completed within a larger assessment
battery. Interested parents were provided with study information over the phone and
through email. All children who met the inclusion/exclusion criteria were enrolled in the
study. Informed consent was completed for each participant by the parent and the
individual assessments were conducted within the family home. The parent rated scales
were completed within two weeks before or after the in-person assessment. Following
each assessment, families were given a small stipend and a summary report of their
child’s developmental skills. All data were scored and double-checked at 100%. The data
were then double-entered and verified for 20% accuracy.
Data Analysis
The primary goal of this study was to compare the trajectories of ADHD, ASD,
and anxiety symptoms in boys FXS compared to typically developing children and to
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examine the unique roles that effortful control and cortisol play in these trajectories.
Multilevel modeling (MLM) was used to analyze participants’ trajectories using the R
Project for Statistical Computing and the NLME package (version 2.14.2; R Foundation
for Statistical Computing, 2012). MLM is a strong method for conceptualizing individual
change over time because it uses a single analysis of repeated measures data patterns
(Raudenbush & Bryk, 2002). MLM uses a two-level hierarchical model of within- (Level
1) and between- (Level 2) subject variances to model change and continuity over time.
The Level 1 includes the intercept, which models the individual’s status at the mean age,
and slope, which models the individual’s growth rate. Level 2 describes differences
between individuals in these parameters. MLM accommodates for samples with differing
group sizes and timing of assessments (Raudenbush & Bryk, 2002). MLM was used for
all analyses examining the growth trajectories of the outcome measures (ADHD, ASD,
and anxiety symptoms) as well as the relationship between effortful control and the
outcome measures.
Diagnostic analyses of the data were conducted to examine the key assumptions
of hierarchical linear modeling. Plots of residual and error terms examined the
independence and normality of residuals at Level 1 as well as homoscedasticity of
variance. The data was examined for influential data points including outliers and none
were found.
The CBCL ADHD- and anxiety-raw scores were standardized to make
interpretation meaningful. Age in years and developmental level were centered at the
mean for MLM analyses so that the intercept could be interpreted as the predicted level
of the outcome (ADHD, ASD, and anxiety symptoms) at the mean age/developmental
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level for the sample, this effectively controls for differences in age and development level
across participants.
To assess the primary hypotheses, a series of multilevel unconditional and
conditional models were built testing the effect of effortful control (level 2 predictor) on
the initial level and change of ADHD, ASD, and anxiety symptoms (dependent
variables). Two separate analyses were conducted for each of the dependent variables
(ADHD, ASD, and anxiety symptoms) examining the independent role of effortful
control. Before assessing the role of effortful control on the initial level and change in the
dependent variable, unconditional models were fit to estimate the level and change in the
dependent variable over time illustrated in the following equation illustrating the withinsubjects effects.
Level 1 (within–subjects):

Yti = π0i + π1i Ageti + eti

Level 2 (between-subjects): π0i = β00 + r0i

π1i = β10 + r1i
Yti represents the dependent variable (ADHD, ASD, and anxiety symptoms) for time t
within individual i. π0i and π1i represent the intercept and slope, respectively, for
individual i. eti represents the random error for model. This basic growth model was used
as a foundation for several models to address the hypotheses.
To test the hypothesis that children with FXS will exhibit higher levels of ADHD,
ASD, and anxiety symptoms with relative stability across ages, group membership was
added as a fixed effect to the growth model while controlling for developmental level.
Age varied randomly to model the growth trajectory. The basic growth model with
covariates included:
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Level 1
(Within-Subjects)

Level 2
(Between-Subjects)

Yti = π0i + π1i Age+ π2i Developmental Level+ π3i Group + eti

π0i = β00 + r0i
π1i = β10 + rii
π2i = β20
π3i = β30

To examine whether the level and change in the dependent variable will vary as a
function of effortful control, this predictor was added to the model as a Level 1 effect.
The random effects of effortful control was tested to allow for variability with-in
individuals; however, it was not included in the final model as they were not significant
and did not increase to the model fit.
The final models for each outcome (ADHD, ASD, and Anxiety symptoms)
included the following:
Level 1
(Within-Subjects)

Level 2
(Between-Subjects)

Yti = π0i + π1i Age+ π2i Developmental Level+ π3i Group + π4i Effortful
Control + eti
π0i = β00 + r0i
π1i = β10 + r1i
π2i = β20
π3i = β30
π4i = β40

	
  

The intercept coefficient (π0i) measures the overall level in the outcome as a
function of age (π11), developmental level (π2i), group (π3i), and effortful control (π4i). β
estimates measure the fixed effects while r estimates measure the random effect of age.
Due to the fact that only the first time point was available for the participants with
cortisol data, multi-level modeling could not be used. Multiple linear regression models
were, instead, conducted to assess the relationship between cortisol and the outcome
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measures (ADHD, ASD, and anxiety symptoms) while controlling for age,
developmental level, and group membership.
Diagnostic analyses of the data were conducted to examine the key assumptions
of linear regression. Plots of residual and error terms examined the independence and
normality of residuals as well as homoscedasticity of variance. The data was examined
for influential data points including outliers and none were found. Due to a skewed
distribution, cortisol was transformed using a log base 10 transformation.
To examine the relationship between cortisol levels and ADHD, ASD, and
anxiety symptoms, three separate multiple linear regression models were built. The final
model included cortisol predicting the outcome (ADHD, ASD, and anxiety symptoms)
while controlling for age, developmental level, and group membership, Y=B0+ B 1(Age)+
B 2(Developmental Level)+ B 3(Group)+ ßB4(Cortisol)+ ei. Interaction effects of cortisol
with age and group were tested; however, due to decreased model fit and non-significant
findings, these interaction effects were not included in the final model.
Additionally, other variables were tested as confounding factors in the MLM and
linear regression analyses. Specifically, the form of the Rothbart measure used to
measure effortful control was tested and did relate to ASD outcome measures. This will
be discussed as a limitation of the current study. A dummy coded variable of missing
cortisol was coded and determined not to be a confounding factor.
3.2 RESULTS
ADHD Symptoms
When examining the hypothesis that the FXS group will exhibit higher levels of
ADHD symptoms with relative stability across ages, a series of multi-level models were
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built controlling for developmental level with age and group membership as predictors.
Results of the basic growth model (see Table 3.3- Model 1) indicated no significant
differences in mean levels of ADHD symptoms across the sample (β00 =-0.14, p=0.58).
However, the intercept of the slope is significant (r0i=0.64, p<.0001) indicating
significant variability in ADHD trajectories. Figure 3.1 illustrates the variability in
individual trajectories for each group. The fixed effect of age was significant indicating
that mean levels of ADHD symptoms increase as age increases (β10=0.08, p=0.09). The
random slope of age (r1i=0.08, p=.80) is not significant. Developmental level had a
negative effect on ADHD symptoms such that as developmental level increased, ADHD
symptoms decreased (β20=-0.01, p=0.04). The fixed effect of group membership was not
significant indicating that mean levels of ADHD symptoms did not differ across the
groups (β30=0.21, p=0.51). These results suggest no specific trend in ADHD symptoms
between groups. Figure 3.2 compares the flat trajectories of ADHD symptoms by group.
To examine the hypotheses of lower levels of effortful control predicting higher levels of
ADHD symptoms in both groups effortful control was added as a predictor to the basic
growth model. Effortful control was not found to significantly predict mean levels of
ADHD symptoms (β40=-0.07, p=0.26; Table 3.3 -Model 2).
The results (Table 3.4) of the linear regression model examining the relationship
between cortisol and ADHD symptoms indicated that when controlling for age,
developmental level, and group membership, cortisol levels did not significantly predict
ADHD symptoms (B=0.20, p=0.62). Increasing age (B=0.26, p=0.04) did significantly
predict higher levels of ADHD symptoms.
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ASD Symptoms	
  
To examine the hypothesis that the FXS group will exhibit higher levels of ASD
symptoms with relative stability across ages, a multi-level model was built controlling for
developmental level with age and group as predictors (Table 3.5-Model 1). Results of the
basic growth model indicated that when controlling for developmental level, there were
significant differences in mean levels of ASD symptoms (β00 =19.76, p=0.0000) across
the sample. Additionally, significant variability in individual trajectories was found
(r0i=3.42, p<.0001; See Figure 3.3). While the fixed effect of age was not significant
(β10=-0.08, p=0.82), the random effect of age reached significance indicating that
variability in age among individuals predicted variability in ASD trajectories (r1i=2.15,
p=.002). While developmental level was used a covariate, a significant fixed effect was
found indicating that lower developmental levels related to increased mean levels of ASD
symptoms (β20 =-0.13, p=0.001). Similarly, group membership significantly predicted
differences in ASD symptoms (β30=6.14, p=0.007) indicating that the FXS group
displayed higher mean levels of ASD symptoms. Figure 3.3 illustrates the variability in
individual trajectories across ages for each group. Figure 3.4 displays the mean
differences and growth trajectories in ASD symptoms across groups. To examine the
hypotheses of lower levels of effortful control predicting higher levels of ASD symptoms
in both groups effortful control was added as a predictor to the basic growth model (see
Table 10). Effortful control was not found to significantly predict mean levels of ASD
symptoms (β40=-0.64, p=0.09; Table 3.5-Model 2).
The results (Table 3.6) of the linear regression model examining the relationship
between cortisol and ASD symptoms indicated that when controlling for age,
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developmental level, and group membership, cortisol levels did not significantly predict
ASD symptoms (B=-1.80, p=0.37). Similar to the multi-level modeling results, lower
levels of developmental level related to higher levels of ASD symptoms (B=-0.22,
p=0.01).
Anxiety Symptoms	
  
To examine the hypothesis that the FXS group will exhibit higher levels of
anxiety symptoms with relative stability across ages, a multi-level model was built
controlling for developmental level with age and group as predictors (Table 3.7- Model
1). Results of the basic growth model indicated that when controlling for developmental
level, there were no significant differences in mean levels of anxiety symptoms (β00 =0.23, p=0.45) across the sample; however, the random slope of the intercept was
significant demonstrating variability in anxiety slopes across the sample (r0i=0.74,
p<.0001; see Figure 3.5). The fixed effect of age did not reach significance indicating
that age did not related to mean levels of anxiety symptoms (β00 =-0.03, p=0.62).
Similarly, the growth rate or the random slope of age was not significant indicating no
variability in trends in anxiety trajectories across ages (r1i=0.000004, p=.99). Mean levels
of anxiety symptoms did not differ across groups (β30 =0.30, p=.44). Figure 3.6 illustrates
the flat trajectories of anxiety symptoms across groups. To examine the hypotheses of
lower levels of effortful control predicting higher levels of anxiety symptoms in both
groups effortful control was added as a predictor to the basic growth model (see Table
3.7- Model 2). Effortful control was not found to significantly predict mean levels of
anxiety symptoms (β40=-0.04, p=0.62).
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The results (Table 3.8) of the linear regression model examining the relationship
between cortisol and anxiety symptoms indicated that when controlling for age,
developmental level, and group membership, cortisol levels did significantly predict
anxiety symptoms (B=0.79, p=0.04). More specifically, higher cortisol levels predicted
higher levels of anxiety.
Post-hoc Analyses
Post-hoc exploratory descriptive analyses were conducted to examine the
comorbidities of elevated symptoms of ADHD, ASD, and anxiety symptoms in the FXS
participants at one or more time points. Table 3.9 presents these results. Nine participants
(15%) had elevated ADHD and ASD symptoms, 1 participant (1.66%) had elevated
ADHD and anxiety symptoms, and 3 participants (5%) had elevated levels of ADHD,
ASD, and anxiety symptoms.
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Table 3.1. Overview of Observation Totals by Predictor Variables

Group

Time
1

Variable
Effortful Control (EC)
60

FXS

2

42

0

3

16

0

Total

119

25

1

34

21

2

5

0

Total

39

21

TD
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Cortisol
25

	
  

Table 3.2. Study 2 Descriptives at First Observation
Group
Variable

n

Age (years)
Developmental
Level
ADHD
Symptoms+
ASD
Symptoms
Anxiety
Symptoms+
Effortful
Control+

60

Cortisol

25

60
60
60
60
60

FXS
M (SD)
Range
4.01
(1.07)
1.5- 5.76
58.38
33- 85
(10.95)
0.2
(0.87)
-2.05- 2.38
27.48
(5.44)
16.5- 42
0.02
(0.94)
-1.16- 3.33
-0.5
(1.06)
-2.74- 2.06
0.33
(0.34)
0.04- 1.79

n
34
34
34
34
34
34
21

TD
M (SD)
3.07
(0.83)
99.53
(9.26)
-0.69
(0.72)
16.21
(2.86)
-0.4
(0.61)
0.6
(0.79)
0.14
(0.13)

Range
1.98- 4.5
85-118
-1.73- 0.8
15-29
-1.16- 0.91
-0.97- 2.35
0.04- 0.52

Developmental Level=Vineland Adaptive Behavior Composite Score
ADHD/ Anxiety Symptoms= Child Behavior Checklist DSM Standardized Raw
Scores
ASD Symptoms= Childhood Autism Rating Scale Total Score
+
Standardized value
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Table 3.3. Linear Model of Growth in ADHD Symptoms
Model 1
Model 2
Variable
Intercept
Growth Rate
(Age)
Developmental
Level
Group
Effortful
Control
Level-1 error

Estimate
-0.14

SE
0.25

Variance
Estimate
0.64*

Estimate
-0.11

SE
0.25

Variance
Estimate
0.62*

0.14**

0.05

0.08

0.15*

0.05

0.05

-0.01*

0.007

-0.01*

0.007

0.21

0.32

0.18

0.32

-0.07

0.06

0.49
χ2 model fit
χ2 model fit improvement=
improvementa=0.06
0.005
a
Note: *p<.05, **p<.01, ***p<.001; Model fit compared to unconditional model
Number of observations: 157
Number of groups: 94
Developmental Level= Vineland Adaptive Behavior Composite Score
ADHD Symptoms= Child Behavior Checklist Standardized DSM ADHD Raw Score
0.47
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Table 3.4. Linear Regression Results of Cortisol Predicting ADHD Symptoms
Variable

B

SE

t-value

p

F

df

p

R2

Intercept

-1.85

1.73

-1.07

0.29

5.41

4, 41

0.001

0.28

Age (years)
Developmental
Level
Group

0.26

0.12

2.15

0.005

0.02

0.31

0.04
0.76

0.82

0.57

1.43

Cortisol

0.20

0.39

0.50

0.16
0.62

Note: n= 46
Developmental Level= Vineland Adaptive Behavior Composite Score
ADHD Symptoms= Child Behavior Checklist Standardized DSM ADHD Raw Score
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Table 3.5. Linear Model of Growth in ASD Symptoms
Model 1
Model 2
Variable
Intercept
Growth Rate
(Age)
Developmental
Level
Group
Effortful
Control
Level-1 error

Estimate
19.76***

SE
1.35

Variance
Estimate
3.42***

Estimate
19.97***

SE
1.35

Variance
Estimate
3.45***

-0.08

0.37

2.15**

0.03

0.37

2.09**

-0.13**

0.04

-0.12**

0.04

6.14***

1.76

5.92**

1.76

-0.64

0.37

1.95
χ2 model fit
χ2 model fit improvement=
a
improvement =9.89**
8.90**
a
Note: *p<.05, **p<.01, ***p<.001; Model fit compared to unconditional model
Number of observations: 157
Number of groups: 94
Developmental Level= Vineland Adaptive Behavior Composite Score
ASD Symptoms= Childhood Autism Rating Scale Total Score
1.97
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Table 3.6. Linear Regression Results of Cortisol Predicting ASD Symptoms
Variable

B

SE

t-value

p

F

df

p

R2

Intercept

39.93

8.85

4.52

.00001

15.9

4, 34

.000000

0.61

Age (years)
Developmental
Level
Group

-1.01

0.61

-1.64

-0.22

0.08

-2.79

0.11
0.01

2.53

3.09

0.82

Cortisol

-1.80

1.97

-0.91

0.42
0.37

Note: n= 39
Developmental Level= Vineland Adaptive Behavior Composite Score
ASD Symptoms= Childhood Autism Rating Scale Total Score
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Table 3.7. Linear Model of Growth in Anxiety Symptoms
Model 1
Model 2
Variance
Estimate
0.74***

Variance
Estimate
0.73***

Variable
Estimate
SE
Estimate
SE
Intercept
-0.23
0.30
-0.22
0.31
Growth Rate
0.04
.000005
0.03
0.06
.000004
0.06
(Age)
Developmenta
-0.001
l
-0.002
0.009
0.009
Level
Group
0.30
0.40
0.29
0.40
Effortful
-0.04
0.08
Control
0.63
0.62
Level-1 error
χ2 model fit
χ2 model fit improvement=
a
improvement =.00000
.00000
a
Note: *p<.05, **p<.01, ***p<.001; Model fit compared to unconditional model
Number of observations: 157
Number of groups: 94
Developmental Level= Vineland Adaptive Behavior Composite Score
Anxiety Symptoms= Child Behavior Checklist Standardized DSM Anxiety Raw Score
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Table 3.8. Linear Regression Results of Cortisol Predicting Anxiety Symptoms
Variable

B

SE

t-value

p

F

df

p

R2

Intercept

-0.46

1.65

-0.28

0.78

1.36

4, 41

0.26

0.03

Age (years)
Developmental
Level
Group

0.04

0.11

0.33

0.74

0.01

0.01

0.44

0.66

0.15

0.55

0.27

0.79

Cortisol

0.79

0.38

2.01

0.04

Note: n= 39
Developmental Level= Vineland Adaptive Behavior Composite Score
Anxiety Symptoms= Child Behavior Checklist Standardized DSM Anxiety Raw Score
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Table 3.9. Descriptives of Group Comorbidities
Age

Developmental
Level
M (SD)
53.11 (10.2)

Groups
n
%`
M (SD)
FXS + ADHD +
9
15%
4.31 (0.6)
ASD
FXS + ADHD +
1
1.66%
5.65
56
Anxiety
FXS + ASD +
0
0.00%
Anxiety
FXS + ADHD +
3
5%
3.45
54.67 (6.81)
ASD + Anxiety
(1.02)
Developmental Level= Vineland Adaptive Behavior Composite Score
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Effortful
Control
M (SD)
-0.38 (1.03)
-0.73

-0.14 (0.81)

	
  

	
  

FXS Group

TD Group

Figure 3.1. Individual trajectories of ADHD symptoms
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FXS	
  
	
  

	
  
TD	
  

Figure 3.2. Comparison of FXS and TD growth trajectories of ADHD symptoms from
ages 2-4 years.
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FXS Group

TD Group

Figure 3.3. Individual trajectories of ASD symptoms
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FXS	
  
	
  

	
  
TD	
  

Figure 3.4. Comparison of FXS and TD growth trajectories of ASD symptoms from ages
2-4 years.
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FXS Group

TD Group

Figure 3.5. Individual Trajectories of Anxiety Symptoms
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FXS	
  
	
  

TD	
  

Figure 3.6. Comparison of FXS and TD growth trajectories of anxiety symptoms from
ages 2-4 years.
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CHAPTER 4
DISCUSSION
Attention-Deficit Hyperactivity Disorder, ASD, and anxiety are three of the most
common mental health disorders in children with higher rates in children with FXS. To
facilitate early intervention and treatment efforts across children with FXS and typically
developing populations, early identification and a better understanding of the precursors
and mechanisms of these disorders is necessary. The neuroconstructivist approach is an
ideal theory because this approach recognizes the bi-directional role of genetics,
cognition, physiology, and behavior interacting over time (Cornish et al., 2004). The
current studies investigated the relationship between impaired effortful control
(precursor) and HPA axis dysfunction (underlying mechanism) and their individual
impacts on the emergence and stability of ADHD, ASD, and anxiety symptoms in boys
with FXS compared to typically developing boys.
Study 1
Consistent with previous literature, the current studies revealed lower levels of
effortful control and higher levels of cortisol in boys with FXS compared to boys of
typical development (Robinson et al., in preparation; Wisbeck et al. 2000; Hessl et al.,
2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Hessl, Rivera, & Reiss, 2004).
While effortful control and cortisol have theoretical and empirical links in young children
(Watamura et al., 2004; Dettling et al., 2000), the current studies do not support this
relationship in children with FXS. Previous research has shown that a negative
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relationship between cortisol levels and parent reported effortful control in typically
developing children ages 12 to 36 months with the strongest relationships in children
ages 24 months of age (Watamura et al., 2004). Similarly, in a sample of typically
developing children ages 3 to 5 years, lower levels of effortful control were related to
increased levels of cortisol (Dettling et al., 2000). While the current sample included
young children of similar ages, no previous studies have examined the relationship
between cortisol and effortful control in clinical samples. Previous findings in typically
developing samples and the null finding in FXS may suggest that the link between
effortful control and cortisol requires typical brain development that is not seen in
children with FXS. However, this is the first study to examine this relationship and future
research is needed to replicate these results and to understand why effortful control and
cortisol may not be related in children with FXS.
Study 2
ADHD, ASD, Anxiety Symptoms in FXS. We hypothesized that children with
FXS would exhibit higher levels of ADHD, ASD, and anxiety symptoms. Group
membership did predict increased levels of ASD symptoms as the FXS displayed higher
mean levels of ASD across all ages. We did not find this same effect with ADHD and
anxiety symptoms. While the current studies focused on symptom severity rather than
diagnostic classification to better address the emergence of symptoms, over 32% of the
FXS participants had clinically significant ASD symptoms, 22.5% had clinically
significant ADHD symptoms, and only 8.75% of the FXS displayed clinically significant
anxiety symptoms. Therefore, ASD symptoms were most prevalent in our study and
consistent with reported prevalence rates of 29% based on CARS total scores in a broader
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age range of boys with FXS (e.g. 18 months to 14 years; Hatton et al., 2006). See Figure
4.1. Our findings support the early emergence of ASD symptoms in young children with
FXS.
The prevalence rates of ADHD and anxiety disorders in our sample are much
lower than reported rates 41- 93% meeting criteria for ADHD (Sullivan et al., 2006) and
86% of males with FXS meeting criteria for anxiety disorders (Cordeiro et al., 2011).
Most previous studies examining prevalence rates of ADHD and anxiety symptoms
within FXS included children and adults ages 5 and up; therefore, our study is one of the
first to examine these behavioral symptoms in young children with FXS. While our
prevalence rates of ADHD and anxiety are far below expectations for children with FXS,
our rates exceed prevalence rates of these disorders in preschool-aged children within the
general population (see Figure 4.2). For example, a meta-analysis of ADHD diagnoses
revealed an average prevalence rate of 10.5% in children ages 3 to 5 years old (Willcutt,
2012), and rates of anxiety disorders in preschoolers have been reported to range from 6.1
to 9.5% (Costello, Egger, and Angold, 2005).
In addition, the increased prevalence rate of ASD symptoms compared to ADHD
and anxiety symptoms is consistent with the average age of diagnosis as ASD can be
reliability diagnosed at 2 to 3 years old with symptoms often appearing as early as 12
months of age (Ozonoff et al., 2010) while ADHD is typically diagnosed between the
ages of 5 and 7 in the general population (CDC, 2010) and anxiety in middle childhood
before the age of 12 (Beesbo, Knappe, & Pine, 2009). Our studies used young children
ages 18 months to 6 years, which falls most in line with the emergence and identification
of ASD. While statistically significant group differences in ADHD and anxiety
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symptoms were not found, elevated symptoms were reported and exceed general
population prevalence rates during the preschool years highlighting the vulnerability of
these young children with FXS.
Developmental trajectories. A major focus of this longitudinal study was to
examine the developmental trajectories of ADHD, ASD, and anxiety symptoms in boys
with FXS compared to typically developing children. The current studies indicate
significant variability in ADHD, ASD, and anxiety trajectories across FXS and typically
developing young boys. More specifically, we did not find specific developmental
trajectories for the FXS group due to the variability of symptoms profiles among
individuals as some showed increases while others decreased and some remain stable
across time. While we hypothesized changes over time in the FXS group, the lack of this
finding is consistent with the heterogeneity of the FXS phenotype. Developmental
changes may be more apparent when examining the trajectories of symptom severity in
more homogeneous groups of children with FXS (i.e. similar developmental levels,
diagnosed ADHD +FXS, etc.). Additionally, developmental changes may been seen later
in childhood and early adolescence as our study focused on the emergence of these
symptom profiles in young children. Due to developmental and cognitive delays in
children with FXS, developmental changes may occur later than the typical population,
which may be evident when examining a broader age range.
Effortful control. Despite significantly lower levels of effortful control in boys
with FXS compared to boys of typical development, effortful control was not found to
significantly predict ADHD, ASD, or anxiety symptoms. The relationships of impaired
effortful control with ADHD and ASD symptoms have been shown in previous studies of
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young children without FXS of similar ages to our sample (Murray & Kochanska, 2002;
Kochanstantareas & Strewart, 2003); however, no studies have examined the link
between effortful control and anxiety in children under the age of 5 indicating that the
link between effortful control and anxiety symptoms is unknown. Our null finding
linking effortful control with ADHD and ASD symptoms in children with FXS was not
expected due to the significant impairments in effortful control that exist in FXS.
However, the fact that effortful control and these behavioral symptoms are not related is
important, as this is the first study to examine these relationships in FXS. FXS is a
multifaceted genetic disorder that causes changes in brain development (Cornish et al.,
2004); therefore, the lack of the relationship between effortful control and these
behavioral outcomes within FXS is still important to our understanding of the FXS
phenotype.
Cortisol. Increased cortisol was found to predict increased anxiety symptoms.
Due to the low prevalence rate of elevated anxiety symptoms in our current FXS sample
compared to previously reported prevalence rates, the relationship between cortisol and
anxiety in the current study was unexpected. The elevated cortisol levels in the FXS
group that link to anxiety symptoms shows the robust role of physiological mechanisms
such that HPA axis dysfunction is evident before behavioral symptoms of anxiety. These
findings may facilitate earlier identification and treatment of anxiety in children within
FXS as physiological dysregulation may serve as a precursor to anxiety symptoms and
disorders.
Cortisol was not found to significantly relate to ADHD or ASD symptoms in the
current study. Previous research in ADHD and ASD groups report decreased cortisol
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levels in the clinical groups compared to typically developing children (Ma, Chen, Chen,
Liu, & Wang, 2011; Ćurin, Terzić, Petković, et. al, 2003). Conversely, FXS literature
suggests overall increased cortisol levels compared to typically developing children
(Wisbeck et al. 2000; Hessl et al., 2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006;
Hessl, Rivera, & Reiss, 2004), which is more similar to clinical groups with anxiety
disorders (Costello et al., 2001). Reduced levels of cortisol have been found to relate to
ASD symptoms in adolescent boys with FXS (Hall, Lightbody, & Reiss, 2008), but there
are mixed findings in the relationship between cortisol levels and ADHD symptoms in
boys with FXS (ages 6-17) as one study found a positive relationship between cortisol
and ADHD symptoms while another did not find a significant relationship between the
two factors (Hessl et al., 2002; Hessl et al., 2002). Therefore, the lack of the relationship
between ADHD and ASD symptoms may be due to the fact that our FXS group showed
increased levels of cortisol instead of decreased levels that are shown in other clinical
groups to relate to ADHD and ASD symptoms. Additionally, previous studies examining
cortisol and behavior outcomes included older age groups than used in the current study
indicating that our participants may not be showing clinically significant symptoms at
young ages.
Limitations
Several limitations need to be noted regarding the current studies. First, the
participants included in these studies were drawn from three related and sequential yet
independent studies on the early development of FXS. Due to the low incidence rates of
FXS, it was important to utilize subjects from all studies; however, two site locations
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were included (UNC and USC) and procedures differed slightly, which may result in site
effects that could confound some results.
Second, our FXS and typically developing participants were not matched on
developmental age. However, a measure of adaptive skills was included and used as a
covariate in our analyses to control for differences in developmental level. This proxy
measure of developmental level was found to strongly correlate with a direct assessment
of developmental or early cognitive skills further supporting its use. While our parent
reported measure was found to be reliable measure of developmental level, it did not
provide an estimate of mental age. Throughout all analyses, the measure of
developmental level was found to relate to effortful control, ADHD symptoms, and ASD
symptoms. Significant group differences in developmental level were expected and found
between the FXS and TD groups. More specifically, the FXS group displayed
significantly lower developmental levels compared to the TD group. Due to the
correlation between developmental level and group membership, the use of
developmental level as a covariate may have accounted for group differences. Similarly,
the effect of effortful control on ADHD, ASD, or anxiety symptoms may have been
overshadowed by the effects of developmental level. The use of developmental level as a
covariate was necessary to account for developmental delays in the FXS; however, it is
not known if additional effects would have been found if developmental level was
accounted for in other ways, such as mental age matching.
Third, due to age related changes in cognitive and temperament development, two
versions of the Rothbart temperament scales were utilized to take into account age related
changes. Two scales based on age (18-36 months, 3-7 years) were included in the
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analyses together so that we could examine the behavioral outcomes across ages. If we
used only the childhood scale (ages 3-7) we would not have been able to examine the
emergence of these behaviors and if we did not include the childhood scale, we would
have lost the longitudinal nature of the study. While strong reliability exists for the use of
these scales, the use of two scales may pose a measurement issue.
Future Directions
Due to the greater negative outcomes associated with co-occurring conditions
within FXS including severe social, academic, and adaptive behavior difficulties (Pearson
et al., 2003; Bailey et al., 2008), early identification and treatment is essential. The
current studies are one of the first to examine comorbidities within FXS and also one of
the first to examine the emergence of these comorbidities by examining behavioral
outcomes in young children with FXS. Examining the emergence of these disorders
highlights the need for a better understanding of the trajectories of these disorders to
better facilitate the timing and specificity of treatment efforts. For example, due to the
link between impaired physiological functioning and anxiety, treatment efforts to reduce
or prevent the development of anxiety symptoms may focus on stress reduction efforts.
Future research may include examining the trajectories of ADHD, ASD, and anxiety
symptoms throughout middle childhood and adolescence to see if developmental profiles
emerge or if individual variability continues. The individual variability in the growth
trajectories of ADHD, ASD, and anxiety across boys with FXS supports the need for
individualized treatment plans of all children with FXS.
The current studies utilized parent rating scales and observer ratings of ADHD,
ASD, and anxiety symptoms. While these procedures are supported in the literature and
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are highly predictive of diagnostic classification, future research should include direct
assessment and diagnostic procedures of ADHD, ASD, and anxiety. More specifically,
our prevalence rates of ASD symptoms is consistent with previous research using the
CARS; however, increased prevalence rates as high as 60-75% of males with FXS have
been shown using direct assessment of ASD specific symptoms such as the Autism
Diagnostic Observation Schedule (Clifford et al., 2007; Hall, Burns, Lightbody, & Reiss,
2008; Harris et al., 2008). No studies to date have used diagnostic measures of ADHD
symptoms in children with FXS as all studies to date have used informant rating scales.
Therefore, the true prevalence rates of ADHD within FXS are not yet known. Future
research may examine the emergence of ADHD, ASD, and anxiety symptoms using
direct assessment to make diagnostic decisions, which may provide more sensitivity in
identifying clinically significant symptoms at early ages. However, the rating scales and
observer ratings are still important as they highlight symptom severity, inform treatment
efforts, and can be used as screening tools.
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Figure 4.1. Comparison of prevalence rates among the general population, FXS
populations, and the current FXS sample.
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